Insulin Resistance Accelerates a Dietary Rat Model of Nonalcoholic Steatohepatitis
Open Access
- 1 January 2007
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 132 (1) , 282-293
- https://doi.org/10.1053/j.gastro.2006.10.014
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- PioglitazoneDrugs, 2006
- Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin SignalingJournal of Biological Chemistry, 2005
- Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined dietBiochemical and Biophysical Research Communications, 2004
- Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver diseaseThe Journal of Pediatrics, 2003
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitisJournal of Clinical Investigation, 2000
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- The Plasminogen–Activating System in Hepatic Stellate CellsHepatology, 1996
- Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strainDiabetes, 1992